Litcius/Paper detail

Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia

Sisi Wang, Lijun Peng, Wenqian Xu, Yuebo Zhou, Ziyan Zhu, Yushan Kong, Stewart Leung, Jin Wang, Xiaoqiang Yan, Jian‐Qing Mi

2021Frontiers of Medicine19 citationsDOI

Topics & Concepts

BlinatumomabCD19CD3AntibodyImmunotherapyCD20Cancer researchLeukemiaT cellIn vivoImmunologyMedicineAntigenImmune systemBiologyCD8BiotechnologyCAR-T cell therapy researchAcute Lymphoblastic Leukemia researchLymphoma Diagnosis and Treatment
Preclinical characterization and comparison between CD3/CD19 bispecific and novel CD3/CD19/CD20 trispecific antibodies against B-cell acute lymphoblastic leukemia: targeted immunotherapy for acute lymphoblastic leukemia | Litcius